MedInnovation: Exciting New Event to Focus on Commercializing Emerging Medical Technologies

Medical Design Briefs INSIDER

A new interactive conference will address key strategies for the commercialization of emerging medical technologies, including the critical steps necessary to move these products to market and how to find the necessary financial resources to make this pathway feasible. The event takes place June 25, 2018, in Boston.

MedInnovation Boston 2018 kicks off with a keynote presentation from John McDonough, President and CEO of T2Biosystems, who will share his experiences and tell what he believes industry must do in emerging medtech for successful product commercialization. The interactive conference offers real, actionable models with sessions that offer tips to ensure success, plus a unique interdisciplinary discussion designed to help companies learn how to maximize innovation. How-to-do-it breakouts are feature actual companies that have seen productive results. Presenters and successful industry leaders walk through how they have brought their emerging technologies to the field.

The luncheon will feature two special guests in a fireside chat. Jeffrey Burbank, CEO and Board Member of NxStage Medical Inc. and Paul Gudonis, Chairman and CEO of Myomo, Inc. will explore the challenges of funding and driving new technologies to market in a Q&A format with Medical Design Briefs editor and director of content Sherrie Trigg. All registrants may join the luncheon to network and be a part of a fireside innovation chat with the keynote speakers.

To register for the event, click here .

The conference is sponsored by MDG Boston and Medical Design Briefs .